In the News
Sponsors name RWD/RWE top opportunity area in clinical research
More than 150 leaders at global biotech and pharmaceutical organizations assessed the therapies in their pipelines, barriers to bringing drugs to market, innovations in pursuit and lingering effects of COVID-19.
Make your clinical trial a priority in a busy landscape
The authors discuss how a more crowded space is presenting new challenges that must be addressed to improve efficiency.
Diversity In Clinical Trials Drives Better Patient Outcomes
The authors explore the latest draft guidance and review industry best practices to increase diversity in clinical trials.
Two Key Questions About Patient Experience in 2022
Soren Skovlund outlines what it takes to be a patient-first organization and how companies can better ensure they are delivering experiences that meet patients’ expectations.
PPD releases R&D trends in pharma and biotech report
Respondents to survey say the top challenge drug developers are currently facing is patient recruitment.
Robust Bioanalytical Studies Can Aid in Regulatory Submissions
Amy Lavelle discusses the challenges of performing bioanalytical studies and how CROs can help mitigate possible regulatory submission problems.
Sponsors already heeding FDA’s call for diversity planning, experts say
Rose Blackburne comments on the FDA’s guidance on trial diversity planning.
Chief Learning Officer reveals 2022 LearningElite award winners
The PPD clinical research business of Thermo Fisher Scientific was named a 2022 LearningElite silver award winner for its exemplary workforce development strategies that deliver significant business results.
Positioning the patient in drug trials
The authors discuss how the clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials.
